METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G2

Clinical trials for METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G2 explained in plain language.

Never miss a new study

Get alerted when new METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G2 trials appear

Sign up with your email to follow new studies for METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Second shot at radiation therapy tested for returning gut tumors

Disease control Recruiting now

This study is for adults with advanced neuroendocrine tumors in the digestive system that have spread and cannot be removed by surgery, and which have started growing again after a previous successful round of a targeted radiation therapy. It aims to see if giving a second round …

Matched conditions: METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G2

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G2

Get alerted when new METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G2 trials appear

Second shot at radiation therapy tested for returning gut tumors